A Predictive Endothelial-Leukemia Pre-Clinical Platform to Uncover Drug Vulnerabilities for Personalized Treatments

MLA

Cappelli, Luca Vincenzo, et al. “A Predictive Endothelial-Leukemia Pre-Clinical Platform to Uncover Drug Vulnerabilities for Personalized Treatments.” Blood, vol. 138, no. 1, Number 1 Supplement 1, Nov. 2021, p. 704. EBSCOhost, https://doi.org/10.1182/blood-2021-153300.

APA

Cappelli, L. V., Fiore, D., Phillip, J. M., Yoffe, L., Di Giacomo, F., Hu, Y., Kayembe, C., Ginsberg, M., Consolino, L., Barcia Durán, J. G., Zamponi, N., Melnick, A., Boccalatte, F., Tam, W., Elemento, O., Chiaretti, S., Guarini, A., Foa, R., Cerchietti, L., … Inghirami, G. (2021). A Predictive Endothelial-Leukemia Pre-Clinical Platform to Uncover Drug Vulnerabilities for Personalized Treatments. Blood, 138(1, Number 1 Supplement 1), 704. https://doi.org/10.1182/blood-2021-153300

Chicago

Cappelli, Luca Vincenzo, Danilo Fiore, Jude M Phillip, Liron Yoffe, Filomena Di Giacomo, Yang Hu, Clarisse Kayembe, et al. 2021. “A Predictive Endothelial-Leukemia Pre-Clinical Platform to Uncover Drug Vulnerabilities for Personalized Treatments.” Blood 138 (1, Number 1 Supplement 1): 704. doi:10.1182/blood-2021-153300.